| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026368519 |
| P356 | DOI | 10.1007/S12016-015-8473-Z |
| P698 | PubMed publication ID | 25687121 |
| P50 | author | Peter Szodoray | Q42574350 |
| P2093 | author name string | Margit Zeher | |
| Ji-Qing Chen | |||
| P2860 | cites work | MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? | Q21144444 |
| MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 | Q22009943 | ||
| Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” | Q22252938 | ||
| TAK1 is a ubiquitin-dependent kinase of MKK and IKK | Q24291454 | ||
| The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells | Q80955813 | ||
| Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma | Q81129108 | ||
| The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis | Q81372115 | ||
| Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA) | Q81918697 | ||
| Multiplex screening of 22 single-nucleotide polymorphisms in 7 Toll-like receptors: an association study in rheumatoid arthritis | Q83089891 | ||
| Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis | Q83419942 | ||
| Activation of JAK-STAT1 signal transduction pathway in lesional skin and monocytes from patients with systemic lupus erythematosus | Q83516720 | ||
| Association study of TLR-9 polymorphisms and systemic lupus erythematosus in northern Chinese Han population | Q85635209 | ||
| Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin | Q24298330 | ||
| A family of cytokine-inducible inhibitors of signalling | Q24313168 | ||
| A new protein containing an SH2 domain that inhibits JAK kinases | Q24313242 | ||
| The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation | Q24318742 | ||
| IRAK: a kinase associated with the interleukin-1 receptor | Q24322162 | ||
| The evolution of vertebrate Toll-like receptors | Q24530086 | ||
| Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells | Q24547568 | ||
| Toll-like receptor signalling | Q24570126 | ||
| Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program | Q24673216 | ||
| The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice | Q28140546 | ||
| Tumor necrosis factor receptor-associated factors (TRAFs) | Q28199382 | ||
| Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1 | Q28206163 | ||
| Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus | Q28212039 | ||
| Toll-like receptors in innate immunity | Q28297257 | ||
| Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors | Q28303818 | ||
| TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta | Q28506630 | ||
| The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors | Q28511605 | ||
| Structure and function of a new STAT-induced STAT inhibitor | Q28584775 | ||
| Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway | Q28592087 | ||
| TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
| Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling | Q28646137 | ||
| Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis | Q28943518 | ||
| Toll-like receptors and their crosstalk with other innate receptors in infection and immunity | Q29547722 | ||
| IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors | Q29618425 | ||
| Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry | Q29618605 | ||
| Role of infectious agents in systemic rheumatic diseases. | Q33380043 | ||
| Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells | Q33609716 | ||
| SOCS1 and SOCS3 in the control of CNS immunity | Q33717795 | ||
| Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. | Q33731760 | ||
| Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome | Q33778661 | ||
| The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products | Q33894375 | ||
| Initial immunopathogenesis of multiple sclerosis: innate immune response. | Q38156767 | ||
| TLR2 and TLR4 in autoimmune diseases: a comprehensive review | Q38172423 | ||
| Emerging role of endosomal toll-like receptors in rheumatoid arthritis | Q38182971 | ||
| U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. | Q38317464 | ||
| Identification of SOCS-3 as a potential mediator of central leptin resistance | Q38335615 | ||
| Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma | Q38380369 | ||
| Expression of TNF-alpha and related signaling molecules in the peripheral blood mononuclear cells of rheumatoid arthritis patients. | Q38402453 | ||
| MicroRNA-mediated mechanism of vitamin D regulation of innate immune response | Q38626414 | ||
| Clinical aspects and treatment of systemic lupus erythematosus | Q38789734 | ||
| Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines | Q39577031 | ||
| Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts | Q39648944 | ||
| Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling | Q39686635 | ||
| CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion | Q39726296 | ||
| Deficient SOCS3 and SHP-1 expression in psoriatic T cells | Q39744026 | ||
| Antimalarials in rheumatology: efficacy and safety | Q39759674 | ||
| Toll-like receptor in salivary glands from patients with Sjögren's syndrome: functional analysis by human salivary gland cell line | Q40149890 | ||
| Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome | Q40170759 | ||
| Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation | Q40328896 | ||
| Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction | Q40437839 | ||
| Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation | Q40497000 | ||
| Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages | Q40708938 | ||
| The role of anti-malarials in rheumatoid arthritis--the American experience. | Q41109179 | ||
| Systemic sclerosis (scleroderma): an integrated challenge in rehabilitation | Q41536190 | ||
| A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases | Q41787535 | ||
| Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis | Q41788599 | ||
| Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures | Q41939782 | ||
| IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients. | Q42264579 | ||
| Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease. | Q42275574 | ||
| Innate immune-related receptors in normal and psoriatic skin | Q42436530 | ||
| Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis | Q42441343 | ||
| The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis | Q42853439 | ||
| Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors. | Q43091811 | ||
| Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated | Q44198173 | ||
| A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis | Q44596853 | ||
| TGF-alpha regulates TLR expression and function on epidermal keratinocytes | Q44714065 | ||
| Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses. | Q44759324 | ||
| Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis | Q44999655 | ||
| Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females | Q45093751 | ||
| Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. | Q45152333 | ||
| Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression. | Q45355670 | ||
| Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus | Q45739890 | ||
| Therapeutic hope for psoriasis offered by SOCS (suppressor of cytokine signaling) mimetic peptide | Q45780399 | ||
| Association of TLR9 gene polymorphisms with lupus nephritis in a Chinese Han population. | Q46557429 | ||
| Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines | Q46605746 | ||
| Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. | Q46614190 | ||
| RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. | Q46687345 | ||
| TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis | Q47789840 | ||
| Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis | Q48062721 | ||
| Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions | Q48463773 | ||
| Extracellular GC-rich DNA activates TLR9- and NF-kB-dependent signaling pathways in human adipose-derived mesenchymal stem cells (haMSCs). | Q49178540 | ||
| Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion. | Q51781016 | ||
| Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis. | Q51886529 | ||
| The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients. | Q53451202 | ||
| Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor gammadelta in plaque and guttate psoriasis. | Q53557801 | ||
| Regulation of TNF-alpha-mediated hyperplasia through TNF receptors, TRAFs, and NF-kappaB in synoviocytes obtained from patients with rheumatoid arthritis. | Q53668963 | ||
| Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome. | Q53709699 | ||
| The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. | Q54430820 | ||
| Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren's syndrome. | Q54432033 | ||
| Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. | Q54505721 | ||
| Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4. | Q54505727 | ||
| TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. | Q54536891 | ||
| Decreased expressions of the TNF-alpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus. | Q54561488 | ||
| Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. | Q55056965 | ||
| Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies | Q56774177 | ||
| A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators | Q57213592 | ||
| Association study of IRAK-M and SIGIRR genes with SLE in a large European-descent population | Q57461647 | ||
| Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus | Q64388181 | ||
| Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis | Q71565785 | ||
| Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis | Q74517333 | ||
| Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands | Q75224600 | ||
| A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists | Q79844593 | ||
| Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis | Q80309322 | ||
| The expression of SOCS is altered in rheumatoid arthritis | Q80860169 | ||
| Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells | Q33935880 | ||
| Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2 | Q33953332 | ||
| TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. | Q34272380 | ||
| Psoriasis--epidemiology and clinical spectrum | Q34291358 | ||
| Toll-like receptors modulate adult hippocampal neurogenesis | Q34664161 | ||
| Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. | Q34858442 | ||
| Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members | Q35079256 | ||
| Proteomic analysis of plasma identifies the Toll-like receptor agonists S100A8/A9 as a novel possible marker for systemic sclerosis phenotype | Q35144377 | ||
| Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium | Q35749232 | ||
| Reading the viral signature by Toll-like receptors and other pattern recognition receptors | Q36001067 | ||
| Investigation of association between the TRAF family genes and RA susceptibility | Q36013813 | ||
| Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies | Q36013878 | ||
| Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation | Q36167500 | ||
| TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome | Q36245745 | ||
| Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization | Q36245841 | ||
| Modulation of life and death by the tumor necrosis factor receptor-associated factors (TRAFs). | Q36296922 | ||
| Innate and adaptive immunity and the pathophysiology of psoriasis | Q36400854 | ||
| Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus | Q36403653 | ||
| Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. | Q36403992 | ||
| Toll-like receptors: applications to dermatologic disease | Q36483506 | ||
| Molecular basis for the unique specificity of TRAF6. | Q36882608 | ||
| TNF signaling: early events and phosphorylation. | Q37026589 | ||
| Statins and demyelination. | Q37065090 | ||
| Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells | Q37139993 | ||
| Matrix metalloproteinases and their inhibitors in connective tissue remodeling | Q37174661 | ||
| No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis | Q37207052 | ||
| Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways | Q37287064 | ||
| Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype | Q37301528 | ||
| Genetic variations in Toll-like receptors (TLRs 3/7/8) are associated with systemic lupus erythematosus in a Taiwanese population | Q37497741 | ||
| Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. | Q37497786 | ||
| Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling | Q37585525 | ||
| Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosis | Q37729213 | ||
| Regulation of remyelination in multiple sclerosis. | Q37858668 | ||
| Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs? | Q37868069 | ||
| P433 | issue | 1 | |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 1-17 | |
| P577 | publication date | 2015-02-17 | |
| P1433 | published in | Clinical Reviews in Allergy & Immunology | Q1932354 |
| P1476 | title | Toll-Like Receptor Pathways in Autoimmune Diseases | |
| P478 | volume | 50 |
| Q37099590 | A Bioinformatics Approach to Prioritize Single Nucleotide Polymorphisms in TLRs Signaling Pathway Genes |
| Q38376039 | Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis |
| Q52331790 | B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex. |
| Q52615452 | Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors. |
| Q38506851 | Beyond adjuvants: Antagonizing inflammation to enhance vaccine immunity |
| Q58692935 | Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-κB pathway quenches intestinal inflammation and oxidative stress injury |
| Q45984203 | Different IL-17-secreting TLR(+) T cell subsets are associated with disease activity in multiple sclerosis. |
| Q47548140 | Distinctive expression of T cell guiding molecules in human autoimmune lymph node stromal cells upon TLR3 triggering |
| Q95276510 | Dysregulation of TLR2 Serves as a Prognostic Biomarker in Breast Cancer and Predicts Resistance to Endocrine Therapy in the Luminal B Subtype |
| Q47826010 | Epidermal barrier reaction to an in vitro psoriatic microenvironment. |
| Q54241736 | Evaluation of the TLR negative regulatory network in CVID patients. |
| Q47933664 | Expression of Toll-Like Receptors in Chronic Histiocytic Intervillositis of the Placenta |
| Q40491107 | Human Endogenous Retroviral Genetic Element With Immunosuppressive Activity in Both Human Autoimmune Diseases and Experimental Arthritis. |
| Q41958567 | IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases |
| Q64967770 | MiR-21 binding site SNP within ITGAM associated with psoriasis susceptibility in women. |
| Q37604349 | MicroRNA-181b negatively regulates the proliferation of human epidermal keratinocytes in psoriasis through targeting TLR4. |
| Q37635819 | Overexpression of suppressor of cytokine signaling 3 in dorsal root ganglion attenuates cancer-induced pain in rats |
| Q94601228 | Ozone Therapy Attenuates NF-κB-Mediated Local Inflammatory Response and Activation of Th17 Cells in Treatment for Psoriasis |
| Q92408958 | Pathogenesis of Important Virulence Factors of Porphyromonas gingivalis via Toll-Like Receptors |
| Q42068012 | Polyene Phosphatidylcholine inhibited the inflammatory response in LPS-stimulated macrophages and ameliorated the adjuvant-induced rat arthritis |
| Q36356021 | Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer |
| Q38840238 | Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models |
| Q38695565 | Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling. |
| Q65001289 | Sjogren's Syndrome and TAM Receptors: A Possible Contribution to Disease Onset. |
| Q64921582 | Sjögren's Syndrome: Animal Models, Etiology, Pathogenesis, Clinical Subtypes, and Diagnosis. |
| Q91714381 | The Role of Immune Modulation in Pathogenesis of IgA Nephropathy |
| Q50158327 | The molecular basis of immune regulation in autoimmunity. |
| Q41979349 | The significance of Toll-like receptor (TLR) 2 and 9 gene polymorphisms in psoriasis |
| Q39529337 | Toll-like receptor 7 involves the injury in acute kidney ischemia/reperfusion of STZ-induced diabetic rats |
| Q90899123 | Toll-like receptor 9 signaling promotes autophagy and apoptosis via divergent functions of the p38/JNK pathway in human salivary gland cells |
| Q38925152 | Toll-like receptors: promising therapeutic targets for inflammatory diseases |
| Q99577395 | Trichinella spiralis: inflammation modulator |
| Q38800476 | What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome? |
| Q37089938 | Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus |
Search more.